{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T22:47:11Z","timestamp":1777070831479,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T00:00:00Z","timestamp":1745107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T00:00:00Z","timestamp":1745107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s12035-025-04934-1","type":"journal-article","created":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T13:31:37Z","timestamp":1745155897000},"page":"10970-10980","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neuroprotective Effects of Cucurbita pepo Extract in Cuprizone-Induced Multiple Sclerosis Animal Model"],"prefix":"10.1007","volume":"62","author":[{"given":"Mohamed","family":"Rahamathulla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yazan","family":"AlRashdan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhura M.","family":"Bose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arumugam","family":"Muthukumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md","family":"Salahuddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed Muqtader","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thippeswamy Boreddy","family":"Shivanandappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2579-4032","authenticated-orcid":false,"given":"Ismail","family":"Pasha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,20]]},"reference":[{"key":"4934_CR1","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1056\/NEJM200009283431307","volume":"343","author":"JH Noseworthy","year":"2000","unstructured":"Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343:938\u2013952","journal-title":"N Engl J Med"},{"key":"4934_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1056\/NEJMra1401483","volume":"378","author":"DS Reich","year":"2018","unstructured":"Reich DS, Lucchinetti CF, Calabresi PA (2018) Multiple sclerosis. N Engl J Med 378:169\u2013180","journal-title":"N Engl J Med"},{"key":"4934_CR3","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri3871","volume":"15","author":"CA Dendrou","year":"2015","unstructured":"Dendrou CA, Fugger L, Friese MA (2015) Immunopathology of multiple sclerosis. Nat Rev Immunol 15:545\u2013558","journal-title":"Nat Rev Immunol"},{"issue":"7374","key":"4934_CR4","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nature10554","volume":"479","author":"K Berer","year":"2011","unstructured":"Berer K, Mues M, Koutrolos M et al (2011) Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 479(7374):538\u2013541","journal-title":"Nature"},{"issue":"2","key":"4934_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2174\/1570159X15666170717120343","volume":"17","author":"JM Vega-Riquer","year":"2019","unstructured":"Vega-Riquer JM, Mendez-Victoriano G, Morales-Luckie RA, Gonzalez-Perez O (2019) Five decades of cuprizone, an updated model to replicate demyelinating diseases. Curr Neuropharmacol 17(2):129\u2013141","journal-title":"Curr Neuropharmacol"},{"key":"4934_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/biomedicines7010014","volume":"7","author":"J Correale","year":"2019","unstructured":"Correale J, Marrodan M, Ysrraelit MC (2019) Mechanisms of neurodegeneration and axonal dysfunction in progressive multiple sclerosis. Biomedicines 7:14","journal-title":"Biomedicines"},{"key":"4934_CR7","doi-asserted-by":"publisher","unstructured":"Gelfand JM (2014) Multiple sclerosis: diagnosis, differential diagnosis, and clinical presentation. Handb Clin Neurol 122:269\u2013290. https:\/\/doi.org\/10.1016\/B978-0-444-52001-2.00011-X","DOI":"10.1016\/B978-0-444-52001-2.00011-X"},{"issue":"47","key":"4934_CR8","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.neubiorev.2014.10.004","volume":"1","author":"J Praet","year":"2014","unstructured":"Praet J, Guglielmetti C, Berneman Z, Van der Linden A, Ponsaerts P (2014) Cellular and molecular neuropathology of the cuprizone mouse model: clinical relevance for multiple sclerosis. Neurosci Biobehav Rev 1(47):485\u2013505","journal-title":"Neurosci Biobehav Rev"},{"key":"4934_CR9","doi-asserted-by":"publisher","unstructured":"B\u00f6 L, Geurts JJ, M\u00f6rk SJ, van der Valk P (2006) Grey matter pathology in multiple sclerosis. Acta neurologica Scandinavica.\u00a0Suppl 183:48\u201350. https:\/\/doi.org\/10.1111\/j.1600-0404.2006.00615.x","DOI":"10.1111\/j.1600-0404.2006.00615.x"},{"key":"4934_CR10","doi-asserted-by":"publisher","unstructured":"Titus HE, Chen Y, Podojil JR, Robinson AP, Balabanov R, Popko B, Miller SD (2020) Pre-clinical and clinical implications of inside-out vs. outside-in paradigms in multiple Sclerosis Etiopathogenesis. Front Cell Neurosci 14:599717. https:\/\/doi.org\/10.3389\/fncel.2020.599717","DOI":"10.3389\/fncel.2020.599717"},{"key":"4934_CR11","first-page":"527","volume":"140","author":"J Correale","year":"2017","unstructured":"Correale J, Gait\u00e1n MI, Ysrraelit MC, Fiol MP (2017) Progressive multiple sclerosis: from pathogenic mechanisms to treatment. Brain 140:527\u2013546","journal-title":"Brain"},{"issue":"4","key":"4934_CR12","doi-asserted-by":"publisher","first-page":"175909141772517","DOI":"10.1177\/1759091417725174","volume":"9","author":"W Zhen","year":"2017","unstructured":"Zhen W, Liu A, Lu J, Zhang W, Tattersall D, Wang J (2017) An alternative cuprizone-induced demyelination and remyelination mouse model. ASN Neuro 9(4):1759091417725174","journal-title":"ASN Neuro"},{"key":"4934_CR13","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s12640-013-9380-9","volume":"24","author":"K B\u00e9nardais","year":"2013","unstructured":"B\u00e9nardais K, Kotsiari A, \u0160kuljec J, Koutsoudaki PN, Gudi V, Singh V, Vulinovi\u0107 F, Skripuletz T et al (2013) Cuprizone [bis(cyclohexylidenehydrazide)] is selectively toxic for mature oligodendrocytes. Neurotox Res 24:244\u2013250","journal-title":"Neurotox Res"},{"key":"4934_CR14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11064-006-9165-0","volume":"32","author":"LA Pasquini","year":"2007","unstructured":"Pasquini LA, Calatayud CA, Bertone U\u00f1a AL, Millet V, Pasquini JM, Soto EF (2007) The neurotoxic effect of cuprizone on oligodendrocytes depends on the presence of pro-inflammatory cytokines secreted by microglia. Neurochem Res 32:279\u2013292","journal-title":"Neurochem Res"},{"issue":"3","key":"4934_CR15","doi-asserted-by":"publisher","first-page":"e02513","DOI":"10.1128\/mBio.02513-14","volume":"6","author":"JR Linden","year":"2015","unstructured":"Linden JR, Ma Y, Zhao B et al (2015) Clostridium perfringens epsilon toxin causes selective death of mature oligodendrocytes and central nervous system demyelination. MBio 6(3):e02513","journal-title":"MBio"},{"key":"4934_CR16","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1600-0404.2008.01036.x","volume":"117","author":"\u00d8 Torkildsen","year":"2008","unstructured":"Torkildsen \u00d8, Brunborg LA, Myhr KM, B\u00f8 L (2008) The cuprizone model for demyelination. Acta Neurol Scand 117:72\u201376","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"4934_CR17","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3390\/toxics2020327","volume":"2","author":"M Manto","year":"2014","unstructured":"Manto M (2014) Abnormal copper homeostasis: mechanisms and roles in neurodegeneration. Toxics 2(2):327\u2013345","journal-title":"Toxics"},{"issue":"283","key":"4934_CR18","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.expneurol.2016.06.033","volume":"1","author":"CB Bai","year":"2016","unstructured":"Bai CB, Sun S, Roholt A, Benson E, Edberg D, Medicetty S, Dutta R, Kidd G et al (2016) A mouse model for testing remyelinating therapies. Exp Neurol 1(283):330\u2013340","journal-title":"Exp Neurol"},{"issue":"909","key":"4934_CR19","doi-asserted-by":"publisher","first-page":"174432","DOI":"10.1016\/j.ejphar.2021.174432","volume":"15","author":"E Khaledi","year":"2021","unstructured":"Khaledi E, Noori T, Mohammadi-Farani A, Sureda A, Dehpour AR, Yousefi-Manesh H, Sobarzo-Sanchez E, Shirooie S (2021) Trifluoperazine reduces cuprizone-induced demyelination via targeting Nrf2 and IKB in mice. Eur J Pharmacol 15(909):174432","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"4934_CR20","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1002\/glia.23058","volume":"64","author":"T Draheim","year":"2016","unstructured":"Draheim T, Liessem A, Scheld M, Wilms F, Weissflog M, Denecke B, Kensler TW, Zendedel A et al (2016) Activation of the astrocytic Nrf2\/ARE system ameliorates the formation of demyelinating lesions in a multiple sclerosis animal model. Glia 64(12):2219\u20132230","journal-title":"Glia"},{"key":"4934_CR21","volume-title":"Traditional medicine strategy 2002\u20132005","author":"World Health Organization","year":"2002","unstructured":"World Health Organization (2002) Traditional medicine strategy 2002\u20132005. World Health Organization, Geneva"},{"key":"4934_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.31254\/phyto.2017.6211","volume":"6","author":"M Adnan","year":"2017","unstructured":"Adnan M, Gul S, Batool S, Fatima B, Rehman A, Yaqoob S, Aziz MA (2017) A review on the ethnobotany, phytochemistry, pharmacology and nutritional composition of Cucurbita pepo L. J Phytopharm 6:133\u2013139","journal-title":"J Phytopharm"},{"key":"4934_CR23","doi-asserted-by":"publisher","first-page":"136","DOI":"10.4081\/aiua.2016.2.136","volume":"88","author":"R Damiano","year":"2016","unstructured":"Damiano R, Cai T, Fornara P, Franzese CA, Leonardi R, Mirone V (2016) The role of Cucurbita pepo in the management of patients affected by lower urinary tract symptoms due to benign prostatic hyperplasia: a narrative review. Arch Ital Urol Androl 88:136\u2013143","journal-title":"Arch Ital Urol Androl"},{"key":"4934_CR24","doi-asserted-by":"publisher","first-page":"11342","DOI":"10.3390\/ijms231911342","volume":"23","author":"C Lubrich","year":"2022","unstructured":"Lubrich C, Giesler P, Kipp M (2022) Motor behavioral deficits in the cuprizone model: validity of the rotarod test paradigm. Int J Mol Sci 23:11342","journal-title":"Int J Mol Sci"},{"key":"4934_CR25","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/hbm.21429","volume":"34","author":"J Gooijers","year":"2013","unstructured":"Gooijers J, Caeyenberghs K, Sisti HM, Geurts M, Heitger MH, Leemans A, Swinnen SP (2013) Diffusion tensor imaging metrics of the corpus callosum in relation to bimanual coordination: effect of task complexity and sensory feedback. Hum Brain Mapp 34:241\u2013252","journal-title":"Hum Brain Mapp"},{"key":"4934_CR26","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/WNN.0000000000000274","volume":"34","author":"S Kobayashi","year":"2021","unstructured":"Kobayashi S, Hirose M, Akutsu Y, Hirayama K, Ishida Y, Ugawa Y (2021) Disconnected motor intention and spatial attention in a case of probable Marchiafava-Bignami disease. Cogn Behav Neurol 34:226\u2013232","journal-title":"Cogn Behav Neurol"},{"key":"4934_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neubiorev.2014.03.008","volume":"43","author":"J Gooijers","year":"2014","unstructured":"Gooijers J, Swinnen SP (2014) Interactions between brain structure and behavior: the corpus callosum and bimanual coordination. Neurosci Biobehav Rev 43:1\u201319","journal-title":"Neurosci Biobehav Rev"},{"key":"4934_CR28","doi-asserted-by":"publisher","unstructured":"Sullivan LM, Weinberg J, Keaney JF Jr (2016) Common statistical pitfalls in basic science research. J Am Heart Assoc 5(10):e004142. https:\/\/doi.org\/10.1161\/JAHA.116.004142","DOI":"10.1161\/JAHA.116.004142"},{"issue":"158","key":"4934_CR29","doi-asserted-by":"publisher","first-page":"105489","DOI":"10.1016\/j.nbd.2021.105489","volume":"1","author":"X Zhu","year":"2021","unstructured":"Zhu X, Yao Y, Hu Y, Yang J, Zhang C, He Y, Zhang A, Liu X et al (2021) Valproic acid suppresses cuprizone-induced hippocampal demyelination and anxiety-like behavior by promoting cholesterol biosynthesis. Neurobiol Dis 1(158):105489","journal-title":"Neurobiol Dis"},{"issue":"2","key":"4934_CR30","doi-asserted-by":"publisher","first-page":"119","DOI":"10.5115\/acb.2018.51.2.119","volume":"51","author":"GO Omotoso","year":"2018","unstructured":"Omotoso GO, Gbadamosi IT, Afolabi TT, Abdulwahab AB, Akinlolu AA (2018) Ameliorative effects of Moringa on cuprizone-induced memory decline in rat model of multiple sclerosis. Anatomy & cell biology 51(2):119\u2013127","journal-title":"Anatomy & cell biology"},{"issue":"6","key":"4934_CR31","first-page":"636","volume":"6","author":"L Michel","year":"2015","unstructured":"Michel L, Touil H, Pikor NB, Gommerman JL, Prat A, Bar-Or A (2015) B Cells in the multiple sclerosis central nervous system: trafficking and contribution to CNS-compartmentalized inflammation. Front Immunol 6(6):636","journal-title":"Front Immunol"},{"key":"4934_CR32","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.expneurol.2015.11.010","volume":"277","author":"K Ohl","year":"2016","unstructured":"Ohl K, Tenbrock K, Kipp M (2016) Oxidative stress in multiple sclerosis: central and peripheral mode of action. Exp Neurol 277:58\u201367","journal-title":"Exp Neurol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04934-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-04934-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04934-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T11:44:43Z","timestamp":1757159083000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-04934-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,20]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["4934"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-04934-1","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,20]]},"assertion":[{"value":"22 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved and all the animals received human care according to the criteria outlined in the \u201cGuide for the Care and Use of Laboratory Animals\u201d prepared by the National Academy of Sciences and published by the National Institute of Health which is based on the principles of the Declaration of Helsinki. We followed the ARRIVE guidelines [AACP\/IAEC\/40\/NOV2022\/03].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional Review Board Statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}